Investigational Site Number 8400030 — Dallas, Texas

Investigational Site Number 8400030 is a clinical research site located in Dallas, Texas, United States 75230.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number 8400030 has participated in 4 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus.

Sponsors: Sanofi, Hanmi Pharmaceutical Company Limited.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 8400030?

Investigational Site Number 8400030 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 8400030 conducted?

Investigational Site Number 8400030 has 4 clinical trials on record. Their work covers Type 2 Diabetes Mellitus.

Is Investigational Site Number 8400030 accredited by Crixeo Health?

Investigational Site Number 8400030 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 8400030?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.